Physician profile
Christopher Motto
NPI 1710955638
$6,897.58
in general payments reported to CMS, 2019-2025
10 companies · $6,534 in 2025
The $6,534 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.02 · 2022: $135 · 2023: $129 · 2024: $34.55 · 2025: $6,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $660 · Travel and Lodging: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $659.74 |
| Travel and Lodging | $537.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,483.69 | 2025 | |
| Ethicon US, LLC | $103.07 | 2022-2023 | Surgicel Nu-Knit |
| Merck Sharp & Dohme LLC | $85.28 | 2022-2025 | Bridion |
| Davol INC. | $77.57 | 2022-2023 | Phasix Mesh |
| Optinose US, INC. | $41.33 | 2019 | |
| Smith+Nephew, INC. | $38.91 | 2023-2024 | Collagenase Santyl, Regranex |
| Organogenesis INC. | $28.44 | 2025 | Puraply Wound Matrix |
| Kci USA, INC. | $15.60 | 2022 | |
| Covidien LP | $11.90 | 2019 | |
| Acell, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Motto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.